Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- Check5 days agoChange DetectedThe page revision changed from v3.6.5 to v3.6.6, indicating a new version of the study page was published. This appears to be a routine maintenance update to the page metadata rather than substantive content changes.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows a server error indicating the page is unavailable, and the detailed study content has been removed, leaving an inaccessible study record for NCT03631407.SummaryDifference19%

- Check40 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3. This reflects a small backend/versioning update and does not change visible study information.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the prior v3.6.2, indicating a minor version update. This update is a software release note and does not affect the study content or visible functionality on the page.SummaryDifference0.0%

- Check69 days agoChange DetectedDifference0.0%

- Check83 days agoChange DetectedThe page adds a recruitment status line and new navigation/help sections, updates the Intervention/Treatment heading, and includes a revision tag (Revision: v3.6.0) replacing the previous version.SummaryDifference0.4%

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.